|
Hormones
In order to speed weight gain, many feedlot managers give
cattle growth-stimulating hormones - testosterone, estrogens
or progestins - in their feed or via a controlled release
implant in their ears. [1]
The hormones slowly seep into the bloodstream, increasing
hormone levels by two to five times. [2]
A substantial portion of the hormones literally passes through
the cattle into their feces and ends up in the environment,
where it can get into other food and drinking water. The rest
of the hormones remain present in beef.
Testosterone, estrogen and progestin are sex hormones produced
naturally by the human body and are primarily involved in
sexual development. But hormones are very powerful chemicals
- a very small increase or a change in the ratio of hormones
can produce a huge effect in the body, and there is evidence
in both humans and animals that consuming them in the diet
can cause prostate and breast cancer and even cause an animal
to develop the wrong type of sex organs.
It is estimated that 95 percent of beef cattle in the US are
given sex hormones. The EU has banned imports of hormone-treated
beef since 1988, but although Europe's beef industry maintains
that no steroids are used, it has been reported that there
is a black market for these growth promoters for between 5-15
percent of beef cattle. [1]
The use of hormones in organic farming is strictly prohibited,
and even in the EU where they are illegal for all types of
agriculture, the black market means that the only way for
consumers to be confident that their beef is hormone free
is to choose organic.
 |
Bumps on the head (left) mark a reproductively
active male fathead minnow. Female (middle) sports no such
bumps-unless it has been exposed to an androgenic pollutant
such as trenbolone (right). These bumps ordinarily show up
only on breeding males. The exposed females also produced
fewer eggs than unexposed females do. Photos: Ankley et al.
2001. [1]
Environmental estrogen contamination has also been found to
cause abnormal growth, sexual development and puberty in humans,
[4,
5, 6]
and has been linked to fibrocystic disease of the breasts,
polycystic ovaries, menstrual irregularities and infertility.
[4]

Cancer
The potential effects on human health from hormone residues
in beef and beef products include endocrine, developmental
and neurobiological, immunological as well as carcinogenic,
genotoxic and immunotoxicological effects. [7]
Groups most sensitive to the effects of hormones in the diet
are unborn babies, prepubescent children, women (to the effects
of testosterone) and men (to the effects of estrogen). And
the effect of a mixture of low levels of different estrogenic
chemicals is greater than the effects of each individually.
[8]
A European Commission report [9]
has found a spatial and temporal correlation between treating
cattle with hormones and the growing incidence of breast and
prostate cancer and food allergies. [10,
11, 12]
The synthetic hormone diethylstilbestrol (DES), banned by
the US Food and Drug Administration (FDA) in the 1970s, used
to be given to chicken and cattle. This synthetic estrogen
fostered the development of cancer in women. [1]
IGF-1
When a cow is injected with
a hormone called Recombinant Bovine Growth Hormone (rBGH),
it stimulates production of another hormone called Insulin-Like
Growth Factor I (IGF-I). IGF-I is produced naturally in both
humans and cows, but increased levels of this hormone are
believed to be the leading risk factor for prostate and breast
cancer. [13]
Men with high blood-levels of IGF-I are over four times more
likely to develop prostate cancer than are men with lower
levels. Prostate cancer is now the commonest type of cancer
in non-smoking men, with an estimated 185,000 new cases and
39,000 deaths in 1990.
Women with a relatively small increase in IGF-I are up to
seven times more likely to develop pre-menopausal breast cancer
than women with lower levels. Evidence also suggests that
IGF-I increases the risk of childhood cancers.
Monsanto's rBGH
rBGH (also known as Bovine
Somatotropin, BST or Posilac) is manufactured by Monsanto
and is a genetically engineered copy of a naturally-occurring
hormone produced by cows. The side effects associated with
rBGH are so numerous and so potentially dangerous that it
is banned in Canada, the European Union and a number of other
countries. However, rBGH has been in use in other places,
particularly the US, for some years. [13]
Side effects for the cow
Animals treated with rBGH undergo immense stress. Normally,
for about 12 weeks after a cow calves, she produces milk at
the expense of her health. The cow loses weight, is infertile
and is more susceptible to diseases. Eventually, milk output
diminishes and the cow's body begins to recover. By injecting
rBGH, a farmer can postpone that recovery for another eight
to 12 weeks, substantially increasing the cow's milk output,
but also rendering her more susceptible to disease. [13]
The label on Posilac warns of 21 cattle health problems associated
with its use, including cystic ovaries, uterine disorders,
decreased gestation period, decreased calf birth weight, increased
twinning rates and retained placenta. Other problems include
abortions, open sores and deformed calves.
The most widely reported and serious problem, however, is
the increased risk of mastitis, or inflammation of the udder.
A cow with mastitis produces milk with pus in it. Dairies
will not accept milk with a high proportion of pus, and mastitis
can thus be a serious source of lost revenue to the dairy
farmer. Many farmers try to solve the problem by using antibiotics,
but antibiotic residues in milk are suspected of causing health
problems in humans who drink it and contributing to the spread
of antibiotic resistant bacteria.
Side effects for the milk drinker
Apart from the ill effects of drinking antibiotics or pus,
rBGH has also been linked to cancer. In 1993, Monsanto had
admitted that rGBH increases the level of IGF-I in milk by
about five-fold, though it has been estimated that this figure
may be up to ten-fold. [13]
IGF-I is not destroyed by pasteurization or digestion in the
stomach and is easily absorbed by the human body. Unpublished
tests by Monsanto revealed "significant growth stimulating
effects" (which can lead to cancer) in organs of adult
rats fed very low doses of IGF-I.
Researchers at the University of Illinois, Chicago have reported
that IGF-I from rBGH treated cows may lead to breast and colon
cancer in human milk-drinkers. Another study published in
The Lancet found a seven-fold increase in the risk of breast
cancer among pre-menopausal women with high levels of IGF-I
in their blood. A study published in Science found a four-fold
increase in the risk of prostate cancer among men with high
levels of IGF-I in their blood.
Unnecessary
Daily injections of rBGH increase a cow's milk yield by between
10 and 20 percent. But since the 1950's, US dairies have been
producing more milk than the country can drink and the government
must buy the surplus to prevent the price from plummeting.
rBGH generates an annual income of between US$ 300 and $500
million for Monsanto. [13]
Unwanted
Surveys have shown that more than 70 percent of American consumers
do not want to drink rBGH milk, but they are denied a legal
right to know how their milk is produced. Since 1994, retailers
were threatened with legal action if they labeled milk as
"rBGH free." The FDA explained that there was "virtually"
no difference between rBGH milk and ordinary milk and that
labeling would thus unfairly discriminate against companies
like Monsanto.
In April 1994, Monsanto won a lawsuit against the State of
Vermont, where rBGH was legally required to be labeled, on
the grounds that the "unconstitutional" law violated
the First Amendment, which asserts a constitutional right
not to be forced to disclose information.
Monsanto has now reluctantly abandoned its lawsuits against
retailers, and labeling milk 'BGH-free' is now permitted in
the US. But the FDA still refuses to require producers to
so label their milk, so even now, many people have no idea
what they are really drinking.
Untested
rBGH was never properly tested before being approved by the
FDA. A standard cancer test of a new human drug requires two
years of testing with several hundred rats. But rBGH was tested
for only 90 days on 30 rats. [13]
This study was never published and the FDA has refused to
allow anyone outside the administration to review the data,
saying it would "irreparably harm" Monsanto.

| Hormone
references |
| [1] |
Raloff,
J. (2002). Hormones: Here's the Beef. Science News.
161 (1). |
| [2] |
Mason, J. and Singer, P. (1990). Animal
Factories. New York. NY: Harmony Books. 51; Jeannine Kenney
and Dick Fallert, (Jul - Sep, 1989). Livestock Hormones
in the United States. National Food Review. 22-23. |
| [3] |
Fritsche,
S. et al. (2001). Growth promoting implants affect
fatty acid composition including conjugated linoleic acid
isomers in subcutaneous fat of beef steers. USDA Agricultural
Research Service. |
| [4] |
P?rez-Comas, A. (1988). Premature
Sexual Development in Puerto Rico. Boletin Asociacion
Medica de Puerto Rico. 80; 85-90. |
| [5] |
Sanders, T.A.B. (1999). Food production
and food safety. BMJ. 318; 1689-1693. |
| [6] |
Kestin, S.C., Su, G. and Sorensen,
P. (1999). Different commercial broiler crosses have
different susceptibilities to leg weakness. Poultry
Science. 78, 1085-1090. |
| [7] |
European Commission (1999). Assessment
of potential risks to human health from hormone residues
in bovine meat and meat products. Opinion of the scientific
committee on veterinary measures relating to public health. |
| [8] |
Silva, E., Rajapakse, N. and Kortenkamp,
A. (2002). Something from nothing - eight weak estrogenic
chemicals combined at concentrations below NOEC's produce
significant mixture effects. Environmental Science
and Technology. 36 (8). |
| [9] |
European
Commission (1999). Assessment of potential risks to
human health from hormone residues in bovine meat and
meat products. Opinion of the scientific committee
on veterinary measures relating to public health. |
| [10] |
Parkin, D.M. et al. (eds.) (1997).
Cancer incidence in five continents. Vol VII. IARC
Scientific Publications N? 143. International Agency for
Research on Cancer, Lyon. |
| [11] |
Coleman, M. et al. (1993). Trends
in cancer incidence and mortality. IARC Scientific
Publication N? 121, International Agency for Research
on Cancer, Lyon. |
| [12] |
Dinse, G.E. et al. (1999). Unexplained
increases in cancer incidence in the United States from
1975 to 1994: possible sentinel health indicators?
Annual Review of Public Health. 20; 173-209. |
| [13] |
The
Ecologist (Sept 1998). The Monsanto Issue. |
|